Anixa Biosciences Inc ANIX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:16 AM EDT
2.95quote price arrow down-0.07 (-2.32%)
Volume
16,291
52 week range
2.75 - 5.13
Loading...
  • Open2.99
  • Day High3.02
  • Day Low2.95
  • Prev Close3.02
  • 52 Week High5.13
  • 52 Week High Date01/18/24
  • 52 Week Low2.75
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap94.104M
  • Shares Out31.90M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-22.16

KEY STATS

  • Open2.99
  • Day High3.02
  • Day Low2.95
  • Prev Close3.02
  • 52 Week High5.13
  • 52 Week High Date01/18/24
  • 52 Week Low2.75
  • 52 Week Low Date11/22/23
  • Market Cap94.104M
  • Shares Out31.90M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-22.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.34
  • P/E (TTM)-8.64
  • Fwd P/E (NTM)-6.70
  • EBITDA (TTM)-11.903M
  • ROE (TTM)-41.01%
  • Revenue (TTM)209,999.993
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,174.29%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date06/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anixa Biosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine...
Amit Kumar Ph.D.
Chairman of the Board, Chief Executive Officer
Michael Catelani
President, Chief Financial Officer, Chief Operating Officer, Company Secretary
Address
3150 Almaden Expy Ste 250
San Jose, CA
95118
United States

Top Peers

SYMBOLLASTCHG%CHG
CRVS
Corvus Pharmaceuticals Inc
1.88-0.03-1.57%
ELTX
Elicio Therapeutics Inc
8.90-0.08-0.89%
ALVR
Allovir Inc
0.791-0.0154-1.9097%
IOBT
IO Biotech Inc
1.47-0.02-1.34%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
2.99+0.05+1.70%